Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

attenuated corynebacterium parvum

A heat-inactivated preparation of Corynebacterium parvum with immunoadjuvant properties. Therapeutic Corynebacterium parvum may stimulate host antitumor immune responses when added to cancer vaccines.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	C. parvum Propionibacterium acnes therapeutic Corynebacterium parvum
US brand name:	Coparvax Corynebacterium parvum, Burroughs Corynebacterium parvum, Merieux
Abbreviation:	CPAR

attenuated corynebacterium parvum

Search NCI's Drug Dictionary